SLC5A2 and lung disorder: We employed this method, leveraging extensive Genome-Wide Association Studies (GWAS) and identified single nucleotide polymorphisms (SNPs) associated with SGLT2 inhibitors, to establish the causal relationship between SGLT2 inhibitors and pulmonary diseases.